Cornerstone Capital Management Holdings’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$707K Buy
+43,200
New +$643K ﹤0.01% 959
2016
Q1
Sell
-9,800
Closed -$89K 1546
2015
Q4
$89K Sell
9,800
-36,400
-79% -$280K ﹤0.01% 1320
2015
Q3
$260K Sell
46,200
-2,400
-5% -$19.8K ﹤0.01% 1166
2015
Q2
$539K Buy
48,600
+25,400
+109% +$327K ﹤0.01% 987
2015
Q1
$364K Buy
23,200
+16,000
+222% +$248K ﹤0.01% 1079
2014
Q4
$110K Buy
+7,200
New +$87.4K ﹤0.01% 1153

Other funds holding SGMO

Cornerstone Capital Management Holdings's SGMO Position: Q4 2017 in Review

Cornerstone Capital Management Holdings opened a new position in SANGAMO THERAPEUTICS INC (SGMO) in Q4 2017: 43,200 shares worth $707K. The stake represents ﹤0.01% of the portfolio and ranks #959 among its holdings. This is a return to the name: Cornerstone Capital Management Holdings previously reported a position in SGMO as recently as Q4 2015.

Cornerstone Capital Management Holdings first reported a position in SGMO in Q4 2014 and has held it in 6 quarters since. 170 funds tracked by Wall St. Rank hold SGMO as of Q4 2017.

  • Cornerstone Capital Management Holdings held 43,200 shares of SANGAMO THERAPEUTICS INC worth $707K as of Q4 2017.
  • SANGAMO THERAPEUTICS INC was a new Cornerstone Capital Management Holdings position in Q4 2017.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #959 holding.
  • Cornerstone Capital Management Holdings first reported a position in SANGAMO THERAPEUTICS INC in Q4 2014 and has held it in 6 quarters since.
  • 170 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.